NCT06132490

Brief Summary

The main aim of this study is to compare the perioperative effects of different intra-abdominal pressures and different insufflators in patients undergoing robotic surgery at a 30-45 degree trendelenburg position.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2023

Completed
8 months until next milestone

First Posted

Study publicly available on registry

November 15, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

March 15, 2024

Status Verified

September 1, 2023

Enrollment Period

1.5 years

First QC Date

March 20, 2023

Last Update Submit

March 13, 2024

Conditions

Keywords

robotic surgeryintra-abdominal pressureinsufflatorpostoperative painpostoperative complicationsintraoperative complications

Outcome Measures

Primary Outcomes (1)

  • Number of manipulations done by the attending anesthesiologists

    After the induction of general anesthesia, orotracheal intubation and arterial catheterization; a standard ventilation and anesthesia maintenance strategy will be applied. Every manipulation performed to keep the parameters monitored by the anesthesiologists within physiological limits will be recorded: ventilation frequency setting, remifentail infusion titration, administration of vasoactive agents, etc.

    Intraoperative

Secondary Outcomes (24)

  • Arterial blood gas lactate levels

    Intraoperative

  • Peak airway pressures

    Intraoperative

  • Mean airway pressures

    Intraoperative

  • Lung compliance

    Intraoperative

  • End tidal carbon dioxide levels

    Intraoperative

  • +19 more secondary outcomes

Study Arms (2)

Valveless 12

EXPERIMENTAL

Patients scheduled for genitourinary or colorectal robotic surgery, valveless insufflators will be used with 12 mmHg intra-abdominal pressure.

Device: Valveless Insufflator with 12 mmHg intra-abdominal pressure

Valveless 8

EXPERIMENTAL

Patients scheduled for genitourinary or colorectal robotic surgery, valveless insufflators will be used with 8 mmHg intra-abdominal pressure.

Device: Valveless Insufflator with 8 mmHg intra-abdominal pressure

Interventions

In this group valveless insufflators, which are relatively new in clinical practice, will be used under low intra-abdominal pressure throughout the surgery.

Valveless 12

In this group valveless insufflators, which are relatively new in clinical practice, will be used under ultra-low intra-abdominal pressure throughout the surgery.

Valveless 8

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective robotic surgery with intraabdominal insufflation and trendelenburg position (prostatectomy, hemicolectomy etc.)
  • ASA (American Society of Anesthesiologists) Physical Status I-II-III

You may not qualify if:

  • Patients without consent
  • Emergency surgery
  • Bleeding diathesis
  • Pregnancy or lactation
  • Prior history of major abdominal/pelvic surgery
  • Chronic kidney disease
  • Chronic opioid consumption for chronic pain
  • Inability to communicate with the patient due to language barriers or mental status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koç University

Istanbul, 34010, Turkey (Türkiye)

Location

Related Publications (4)

  • Feng TS, Heulitt G, Islam A, Porter JR. Comparison of valve-less and standard insufflation on pneumoperitoneum-related complications in robotic partial nephrectomy: a prospective randomized trial. J Robot Surg. 2021 Jun;15(3):381-388. doi: 10.1007/s11701-020-01117-z. Epub 2020 Jul 6.

    PMID: 32632561BACKGROUND
  • Horstmann M, Horton K, Kurz M, Padevit C, John H. Prospective comparison between the AirSeal(R) System valve-less Trocar and a standard Versaport Plus V2 Trocar in robotic-assisted radical prostatectomy. J Endourol. 2013 May;27(5):579-82. doi: 10.1089/end.2012.0632. Epub 2013 Feb 5.

    PMID: 23186377BACKGROUND
  • Paull JO, Parsacandola SA, Graham A, Hota S, Pudalov N, Obias V. The impact of the AirSeal(R) valve-less trocar system in robotic colorectal surgery: a single-surgeon retrospective review. J Robot Surg. 2021 Feb;15(1):87-92. doi: 10.1007/s11701-020-01071-w. Epub 2020 Apr 24.

    PMID: 32333365BACKGROUND
  • La Falce S, Novara G, Gandaglia G, Umari P, De Naeyer G, D'Hondt F, Beresian J, Carette R, Penicka M, Mo Y, Vandenbroucke G, Mottrie A. Low Pressure Robot-assisted Radical Prostatectomy With the AirSeal System at OLV Hospital: Results From a Prospective Study. Clin Genitourin Cancer. 2017 Dec;15(6):e1029-e1037. doi: 10.1016/j.clgc.2017.05.027. Epub 2017 Jun 2.

    PMID: 28669704BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeHypercapniaPostoperative ComplicationsIntraoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsSigns and Symptoms, Respiratory

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient and the pain nurses will be blind to the intervention due to the study design.
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2023

First Posted

November 15, 2023

Study Start

July 15, 2022

Primary Completion

December 30, 2023

Study Completion

December 30, 2023

Last Updated

March 15, 2024

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share

Data collected for the study, including de-identified individual participant data will be made available to other within 6 months after the publication of this trial, as will additional related documents (study protocol, statistical analysis plan and informed consent form), for academic purposes (e.g , meta-analyses) upon request to the corresponding author, and with a signed data access agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
6 months after the publication
Access Criteria
Academic purposes

Locations